Remove Clinical Trials Remove Cultivation Remove Data Remove Events
article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Press Release: Canada – Princeton mushroom research and development facility officially opens, sells first grow of psilocybin mushrooms

Cannabis Law Report

A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. And there are literally hundreds of trials that are being done, and more forthcoming.”. Optimi Health Corp.

article thumbnail

Flora Growth Announces Patent-Pending Cannabinoid-Based Product, Seeks INVIMA (Colombian FDA) Emergency Use Authorization Under COVID-19 Protocols

Cannabis Law Report

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). Dr. Manalo-Morgan has spent the last 5 years researching cannabis and has specialized in the formulation of cannabinoid products for clinical trials.

article thumbnail

Flora Growth Appoints Industry Authority Tim Leslie as Chairman of Its Newly Formed Advisory Board

Cannabis Law Report

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the Chairman of its newly formed Advisory Board.

article thumbnail

Press Release: EMMAC and Imperial College London manuscript to be published in peer-reviewed Cannabis and Cannabinoid Research Journal

Cannabis Law Report

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. About EMMAC.

article thumbnail

Oregon proposes only using one type of mushroom for new psilocybin system, and no pills

Cannabis Law Report

These are the very first draft rules that we’re seeing, so it really is a kind of pivotal event.”. But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research.